A major study has pinpointed more than 100 genetic risk factors that explain why some people suffer from asthma, hay fever and eczema.
The study led by Dr Manuel Ferreira from QIMR Berghofer Medical Research Institute explained that this was the first study designed specifically to find genetic risk factors that are shared among the three most common allergic conditions.
"Asthma, hay fever and eczema are allergic diseases that affect different parts of the body: the lungs, the nose and the skin," he said. "We already knew that they were similar at many levels. For example, we knew that the three diseases shared many genetic risk factors. What we didn't know was exactly where in the genome those shared genetic risk factors were located."
"This is important to know because it tells us which specific genes, when not working properly, cause allergic conditions. This knowledge helps us understand why allergies develop in the first place and, potentially, gives us new clues on how they could be prevented or treated," Dr Ferreira added.
"We analysed the genomes of 360,838 people and pinpointed 136 separate positions in the genome that are risk factors for developing these conditions," he continued. "If you are unlucky and inherit these genetic risk factors from your parents, it will predispose you to all three allergic conditions."
He said those 136 genetic risk factors influenced whether 132 nearby genes were switched on or off.
Dr Ferreira also stated that these genes the risk of asthma, hay fever and eczema by affecting the immune system work.
"Importantly, we have identified several drugs that we believe could be targeted at some of these genes to treat allergies. The first step would be to test those drugs in the laboratory."
The study also examined if environmental factors might affect whether these genes are switched on or off.
"We found that this could be happening for many of the genes we identified," Dr Ferreira said.
The study appears in the journal of Nature Genetics.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
